However, increasing shikonin decreased the protein level of PKM2, decreased the phosphorylation level of ERK1/2 and the expression level of GLUT1 protein, and inhibited the progression of PAH (Li et al., 2023). This evidence concerns the gene SLC2A1 and pulmonary arterial hypertension.